ARCHIVES

“Sloppy Work” May Invalidate Methylene Chloride Study; Contractor Hints NTP Pressured By Industry

This article is from The Cancer Letter archive.

Vol. 09 No. 39 | October 14, 1983

Download PDF Visit The Full Archive

Related Articles

In Brief: James Cancer Hospial Recieves $20M Donation

January 22, 1999

Also in this 8-page issue: Richard Pazdur named director of FDA’s new Office of Oncology Drug Products.

April 22, 2005

NCI Program: reports Urges Expansion of Surveillance Program To Better Explain Trends

April 30, 1999

DCT Board Okays Recompetition of $15 Million In contract Projects

November 10, 1978

Cancer Rates May Rise 50% By 2020, IARC Says

April 18, 2003

Fake Avastin, Paid for by Medicare, Administered to U.S. Patients

October 3, 2014